AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / LABORATORY ANALYTICAL INSTRUMENTS
908 Devices Inc. Common Stock
XNAS · usd
SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS
FIGI BBG008N1BYS7
11.49▲ 0.14 (1.23%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
11.35
Day's Range
11.05 – 11.49
52-Week Range
5.03 – 13.35
Volume
232.0K
Avg Volume
383.6K
Share Statistics
Shares Outstanding
Employees
172
Exchange
XNAS
Listed
2020-12-18
Share count as of August 7, 2026

908 Devices Inc. Common Stock (MASS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about 908 Devices Inc. Common Stock (MASS)
What is 908 Devices Inc. Common Stock's Market Cap?
908 Devices Inc. Common Stock's Market Cap is $474.9M, based on as-reported figures from SEC (XBRL) filings.
What is 908 Devices Inc. Common Stock's Price / Sales?
908 Devices Inc. Common Stock's Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.
What is 908 Devices Inc. Common Stock's Revenue (TTM)?
908 Devices Inc. Common Stock's Revenue (TTM) is $60.8M, based on as-reported figures from SEC (XBRL) filings.
What is 908 Devices Inc. Common Stock's Net Income (TTM)?
908 Devices Inc. Common Stock's Net Income (TTM) is -$34.7M, based on as-reported figures from SEC (XBRL) filings.
What is 908 Devices Inc. Common Stock's EBITDA?
908 Devices Inc. Common Stock's EBITDA is -$34.2M, based on as-reported figures from SEC (XBRL) filings.
What is 908 Devices Inc. Common Stock's Diluted EPS (TTM)?
908 Devices Inc. Common Stock's Diluted EPS (TTM) is -0.84, based on as-reported figures from SEC (XBRL) filings.
What is 908 Devices Inc. Common Stock's EBITDA Margin?
908 Devices Inc. Common Stock's EBITDA Margin is -56.3%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · MASSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue:
YoY growth+23.3%+13.6%+21.2%-3.5%
Cost of revenue:
Gross profit
% of revenue51.9%51.4%52.7%52.5%
Operating expenses:
Research and development
Selling, general and administrative
Change in fair value of contingent consideration
Total operating expenses
% of revenue131.6%147.7%34.9%169.1%
Loss from continuing operations
% of revenue-79.7%-96.3%17.8%-116.6%
Other income, net:
Interest income
Income from transition services agreement, net——
Other expense, net
Total other income, net
Loss from operations before income taxes—
Income tax benefit (expense), net—
Net loss from continuing operations
Net income (loss) attributable to common stockholders
% of revenue-74.0%-89.3%24.0%-107.0%
Net loss from continuing operations per share attributable to common stockholders, basic
Net loss from continuing operations per share attributable to common stockholders, diluted
Net income (loss) from discontinued operations per share attributable to common stockholders, basic——
Net income (loss) from discontinued operations per share attributable to common stockholders, diluted—
Net income (loss) per share attributable to common stockholders, basic
Net income (loss) per share attributable to common stockholders, diluted